Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Notes Payables (2020 - 2025)

Historic Notes Payables for Catheter Precision (VTAK) over the last 5 years, with Q3 2025 value amounting to $1.7 million.

  • Catheter Precision's Notes Payables rose 58273.09% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 58273.09%. This contributed to the annual value of $1.6 million for FY2024, which is 76956.52% up from last year.
  • Catheter Precision's Notes Payables amounted to $1.7 million in Q3 2025, which was up 58273.09% from $1.7 million recorded in Q2 2025.
  • In the past 5 years, Catheter Precision's Notes Payables ranged from a high of $14.2 million in Q2 2023 and a low of $7592.0 during Q1 2023
  • Over the past 4 years, Catheter Precision's median Notes Payables value was $1.6 million (recorded in 2024), while the average stood at $3.9 million.
  • The largest annual percentage gain for Catheter Precision's Notes Payables in the last 5 years was 9289262.38% (2024), contrasted with its biggest fall of 9824.43% (2024).
  • Over the past 4 years, Catheter Precision's Notes Payables (Quarter) stood at $674000.0 in 2021, then plummeted by 72.7% to $184000.0 in 2023, then skyrocketed by 769.57% to $1.6 million in 2024, then rose by 6.25% to $1.7 million in 2025.
  • Its Notes Payables stands at $1.7 million for Q3 2025, versus $1.7 million for Q2 2025 and $1.6 million for Q1 2025.